Pfizer Follows $10bn Metsera Purchase By Licensing YaoPharma Obesity Asset

 
• By Joseph Haas
  
Pfizer
Pfizer continues building its obesity portfolio via licensing deal with YaoPharma • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business